Medication Fact Sheets
|
February 4, 2025

Flecainide Explained: Uses, Benefits, and Side Effects

Written By
Dr. Kristin Robinson ND
Medically Reviewed by
Updated On
February 24, 2025

Did you know that an estimated 12 million individuals in the U.S. will have atrial fibrillation (AFib) by 2030? This growing statistic highlights just how common heart arrhythmias have become.

Medications like flecainide are often prescribed for many individuals affected by arrhythmias to help restore a regular heart rhythm. However, you should consult your healthcare provider to determine if flecainide is the proper treatment for you. 

This article provides an overview of flecainide, explaining how it works, its benefits, and possible side effects.

[signup]

What is Flecainide?

Flecainide is a prescription medication used to help monitor certain heart arrhythmias or irregular heart rhythms. As an antiarrhythmic drug, it stabilizes the electrical signals in the heart to help restore a regular rhythm.

Doctors may prescribe flecainide when other treatments, such as lifestyle changes or medications like beta-blockers, are ineffective. However, it should always be used under the guidance of a healthcare provider, as it may not be suitable for everyone.

History of its Development and Approval

Flecainide was developed in 1966 and synthesized in 1972 to address the need for more effective treatments for arrhythmias. The FDA approved it in 1986. Since then, it has become an important medication for managing certain heart rhythm disorders. Over time, healthcare providers have refined how flecainide balances effectiveness and safety.

How Does Flecainide Work?

Electrical signals regulate the heart's rhythm, helping it beat in a coordinated pattern. When these signals become irregular, arrhythmias can occur. Flecainide stabilizes these electrical signals, allowing the heart to maintain a more consistent rhythm. However, healthcare providers should only prescribe flecainide for certain types of arrhythmias.

Mechanism of Action

Flecainide works by blocking sodium channels in the heart, which are responsible for carrying electrical signals. By slowing these signals, flecainide helps prevent irregular heartbeats in arrhythmias.

Think of the heart's electrical system like a busy road. If too many cars (electrical signals) get on the road too quickly, it causes a traffic jam (arrhythmia). Flecainide acts like a traffic controller, slowing the flow to keep things moving smoothly and preventing disruptions.

By modifying the speed at which electrical signals travel, flecainide supports a more consistent heart rhythm. However, it’s important to note that flecainide is not right for all types of arrhythmias and should be used under the supervision of a healthcare provider.

Common Uses of Flecainide

Doctors often prescribe flecainide to help manage certain heart arrhythmias or irregular heart rhythms.

Primary Indications

It primarily treats arrhythmias such as atrial fibrillation (AFib) and supraventricular tachycardia (SVT).

  • AFib is a common arrhythmia where the heart's upper chambers beat irregularly, often too quickly. Flecainide helps restore a regular rhythm and can reduce symptoms like palpitations and dizziness.

  • SVT causes the heart to beat abnormally fast due to irregular electrical signals above the ventricles. Flecainide slows these signals to help stabilize the heart rate.

Flecainide may also be used for ventricular tachycardia (VT), a more serious arrhythmia in the heart's lower chambers (ventricles). Flecainide should only be used for these conditions under the supervision of a healthcare provider.

Off-Label Uses

In addition to its primary uses, flecainide may be prescribed off-label, meaning for conditions not explicitly approved by the FDA but supported by clinical experience.

For instance, flecainide may be used to manage certain cases of atrial flutter or when other treatments haven't worked. It is also used off-label to treat supraventricular tachycardia in children, a rapid heart rate originating in the heart's upper chambers. Additionally, flecainide may be prescribed for sustained fetal tachycardia, a fast heart rate in an unborn baby.

However, you should always discuss off-label uses with your healthcare providers.

Flecainide Safety and Dosing Guidelines

When considering flecainide, following safety precautions and dosing recommendations is important to ensure its safe and effective use. Flecainide should be used with caution, particularly for those with certain health conditions, and only under the supervision of a healthcare provider.

Safety Precautions

  • Flecainide is not suitable for individuals with severe heart failure, recent heart attack, or advanced heart block. Discuss your medical history with your healthcare provider before starting treatment.

  • Regular monitoring, such as ECGs, may be needed to ensure the medication is working as intended and to check for potential side effects.

  • Flecainide can interact with other medications, so be sure to inform your doctor about all prescriptions, over-the-counter drugs, and supplements you're taking.

  • Since the liver and kidneys process flecainide, individuals with liver or kidney concerns may require a lower starting dose. Your healthcare provider will determine the appropriate dosage for you.

Dosing Recommendations

Flecainide dosing depends on factors such as the specific arrhythmia being treated and the individual’s overall health. Most adults begin with a dose of 50 to 100 mg every 12 hours to minimize the risk of side effects. This dose may be adjusted based on how the patient responds to the medication. The maximum recommended daily dose is 400 mg.

For long-term use, flecainide is generally prescribed at a dose that maintains a steady level in the blood to balance effectiveness and safety.

If a dose is missed, it should be taken as soon as remembered unless it is close to the time for the next dose. Do not take two doses at once to make up for a missed dose.

This is general dosing information. Your healthcare provider will determine the appropriate dose for your individual needs.

Side Effects of Flecainide

Flecainide may cause side effects ranging from mild to more serious. It's essential to be aware of potential side effects and consult your healthcare provider if they occur.

Common Side Effects

Most people tolerate Flecainide well, but some may experience side effects, such as:

  • Dizziness
  • Headache
  • Weakness
  • Constipation
  • Stomach pain

These side effects are usually temporary and may lessen as your body adjusts to the medication. If they persist or worsen, it’s important to consult your healthcare provider.

Rare But Serious Risks

If you experience any of these symptoms, seek medical attention immediately.

  • Severe Heart Issues: Flecainide can affect heart rhythm, potentially causing fainting, a very slow or fast heartbeat, or chest pain.

  • Breathing Difficulty or Swelling: Symptoms like shortness of breath, swelling in the legs or ankles,  or rapid weight gain may indicate fluid retention or other serious concerns.

  • Severe Allergic Reactions: Although rare, signs of a severe allergic reaction include a skin rash, itching, swelling of the face or throat, or difficulty breathing.

If you experience any of these symptoms, seek medical attention right away.

Comparing Flecainide to Other Arrhythmia Treatments

Flecainide is one of several treatment options for managing arrhythmias. While it can be effective for certain arrhythmias, it may not be the best option for everyone. Alternative treatments may suit certain individuals, depending on their condition and overall health.

Advantages

Flecainide offers several benefits, especially for specific arrhythmias, such as atrial AFib and SVT:

  • Flecainide is taken orally, which is more convenient than treatments requiring injections or intravenous administration.

  • With decades of use, flecainide is well-understood by healthcare providers and remains a trusted option for many patients.

  • Flecainide can quickly help restore normal rhythm during acute arrhythmia episodes.

Studies show that flecainide is a safe and effective medication for treating atrial fibrillation (AF). It can quickly stop AF and help prevent it from coming back, especially in people who don't have heart structure problems, such as damaged valves, thickened heart walls, or scarring from previous heart attacks.

Recent research suggests a significant rise in flecainide use in the U.S., mainly for preventing atrial fibrillation (AF). Flecainide is highly effective for this purpose and is recommended in the latest AHA/ACC guidelines. Unlike other antiarrhythmic drugs, it can be started outside the hospital, making it more convenient for patients. Its side effect profile is also minimal compared to drugs like amiodarone.

Flecainide is safe for patients with normal heart function and no structural heart disease. The previous concern over its safety stemmed from the 1991 CAST trial, which found it increased mortality in post-heart attack patients with ventricular arrhythmias. However, this risk has not been supported in patients without structural heart issues.

While flecainide is effective for certain arrhythmias, it may not be the right choice for everyone.

Limitations

While flecainide works well for many, there are situations where its limitations may make other treatments more suitable.

  • Flecainide is not recommended for individuals with severe heart failure or advanced heart block, as it may worsen arrhythmias in these cases. Alternative treatments may be more appropriate for these patients.

  • Some individuals experience side effects that may require changing treatments. If side effects persist or worsen, discussing options with your healthcare provider is important.

  • If flecainide is not effective or causes undesirable side effects, other medications, such as beta-blockers, amiodarone, or calcium channel blockers, may be considered.

  • In some cases, flecainide may only be suitable for short-term use. Other strategies, such as catheter ablation or implantable devices, may be more effective for long-term management.

Choosing the best arrhythmia treatment depends on your specific condition, overall health, and how your body responds to the medication. Always consult your healthcare provider to find the most suitable treatment plan.

Emerging Research

New research suggests that flecainide inhalation (FlecIH) could effectively restore normal heart rhythm in people with recent-onset atrial fibrillation. FlecIH is an inhaled form of the antiarrhythmic medication flecainide acetate.

In this study, 42.6% of patients returned to normal rhythm in about 15 minutes after using FlecIH. The conversion rate was higher (46.9%) in those who hadn't taken flecainide. Most patients who responded to the treatment could leave the hospital within 2.5 hours. The side effects were primarily mild, like coughing or sore throat.

FlecIH is a safe and effective option for treating AF quickly. However, further research is needed to confirm its long-term benefits and safety in the broader patient population.

[signup]

Key Takeaways

  • Flecainide manages arrhythmias like atrial fibrillation (AFib) and supraventricular tachycardia (SVT) by stabilizing the heart's electrical signals to restore a regular rhythm.
  • Common side effects include dizziness and headaches, while more serious risks may involve heart complications or allergic reactions.
  • Your doctor can guide you through treatment options, monitor your progress, and adjust medications for your safety and well-being.

 If you have concerns about arrhythmia treatment, contact your healthcare provider for personalized guidance.

The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

Achuff, J. (2024a, March 22). Understanding the Impact of Sweetened Beverages on Heart Rhythm: Insights from a Recent Study. Rupa Health. https://www.rupahealth.com/post/understanding-the-impact-of-sweetened-beverages-on-heart-rhythm-insights-from-a-recent-study

Achuff, J. (2024b, April 4). Understanding Our Body Clocks: A Key to Heart Health. Rupa Health. https://www.rupahealth.com/post/understanding-our-body-clocks-a-key-to-heart-health

AHA. (2023). Implantable Medical Devices. Www.heart.org. https://www.heart.org/en/health-topics/heart-attack/treatment-of-a-heart-attack/implantable-medical-devices

Anderson, S. (2022, September 21). 10 Commonly Prescribed Medications & The Nutrients They Deplete. Rupa Health. https://www.rupahealth.com/post/10-commonly-prescribed-medications-the-nutrients-they-deplete

Andrikopoulos, G. K. (2015). Flecainide: Current status and perspectives in arrhythmia management. World Journal of Cardiology, 7(2), 76. https://doi.org/10.4330/wjc.v7.i2.76

Atrial Fibrillation (Afib). (2022, May 1). Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/16765-atrial-fibrillation-afib

Basza, M., Maciejewski, C., Bojanowicz, W., Balsam, P., Grabowski, M., Mitkowski, P., Kempa, M., Kowalski, O., Kalarus, Z., Jaguszewski, M., Lubiński, A., Daniłowicz-Szymanowicz, L., Szumowski, Ł., Sterliński, M., & Kołtowski, Ł. (2023). Flecainide in clinical practice. Cardiology Journal. https://doi.org/10.5603/cj.a2023.0018

Batra, A. S., & Balaji, S. (2019). Fetal arrhythmias: Diagnosis and management. Indian Pacing and Electrophysiology Journal, 19(3), 104–109. https://doi.org/10.1016/j.ipej.2019.02.007

Bertagna, B. (2024, February 28). Slippery Elm for Sore Throat Relief: Does It Really Work? Rupa Health. https://www.rupahealth.com/post/slippery-elm-for-sore-throat-relief-does-it-really-work

Bryant, A. (2024a, August 2). Understanding Arrhythmias: Types, Symptoms, Diagnosis, and Treatment. Rupa Health. https://www.rupahealth.com/post/arrhythmias-basics-types-symptoms-diagnosis-treatment

Bryant, A. (2024b, September 3). What Should Your Heart Rate Be While Sleeping? A Comprehensive Guid. Rupa Health. https://www.rupahealth.com/post/what-should-your-heart-rate-be-while-sleeping-a-comprehensive-guide

Bryant, A. (2024c, October 21). 10 Lab Tests for Patients With Heart Palpitations. Rupa Health. https://www.rupahealth.com/post/10-lab-tests-for-patients-with-heart-palpitations

Bryant, A. (2024d, November 21). Metoprolol Side Effects: A Complete Guide. Rupa Health. https://www.rupahealth.com/post/metoprolol-side-effects-a-complete-guide

Bryant, A. (2025, January 8). PVC Heart Rhythms: What They Mean and How to Treat Them. Rupa Health. https://www.rupahealth.com/post/pvc-heart-rhythms-what-they-mean-and-how-to-treat-them

CDC. (2024, April 24). About Atrial Fibrillation. Heart Disease. https://www.cdc.gov/heart-disease/about/atrial-fibrillation.html

Cloyd, J. (2023a, April 28). What is the difference between medical-grade supplements and over-the-counter supplements? Rupa Health. https://www.rupahealth.com/post/what-is-the-difference-between-medical-grade-supplements-and-over-the-counter-supplements

Cloyd, J. (2023b, October 9). Rhythms of the Heart: Demystifying Common Types of Heart Arrhythmia. Rupa Health. https://www.rupahealth.com/post/rhythms-of-the-heart-demystifying-common-types-of-heart-arrhythmia

Cloyd, J. (2024a, January 19). Understanding the Role of Kidney Function Tests in Comprehensive Health Assessments. Rupa Health. https://www.rupahealth.com/post/understanding-the-role-of-kidney-function-tests-in-comprehensive-health-assessments

Cloyd, J. (2024b, December 16). 6 Warning Signs of a Heart Attack a Month Before It Happens. Rupa Health. https://www.rupahealth.com/post/6-potential-warning-signs-of-a-heart-attack-before-it-happens

Daglis, S. (2024a, August 7). Tachycardia: Don’t Let Your Heart Run Away with You. Rupa Health. https://www.rupahealth.com/post/tachycardia-dont-let-your-heart-run-away-with-you

Daglis, S. (2024b, December 27). How Metoprolol Succinate Works: A Complete Guide. Rupa Health. https://www.rupahealth.com/post/how-metoprolol-succinate-works-a-complete-guide

Echt, D., & Ruskin, J. (2020). Use of Flecainide for the Treatment of Atrial Fibrillation. The American Journal of Cardiology, 125(7), 1123–1133. https://doi.org/10.1016/j.amjcard.2019.12.041

Heart Block: Types, Symptoms & Causes. (2023, August 25). Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/17056-heart-block#overview

Jackson, K. (2024, August 30). Heart Skips a Beat: Understanding Causes and When to Seek Help. Rupa Health. https://www.rupahealth.com/post/heart-skips-a-beat-understanding-causes-and-when-to-seek-help

Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., Gorenek, B., Hess, P. L., Hlatky, M., Hogan, G., Ibeh, C., Indik, J. H., Kido, K., Kusumoto, F., Link, M. S., & Linta, K. T. (2023). 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 149(1). https://doi.org/10.1161/CIR.0000000000001193

John Hopkins Medicine. (2019). Anatomy and Function of the Heart’s Electrical System. Johns Hopkins Medicine. https://www.hopkinsmedicine.org/health/conditions-and-diseases/anatomy-and-function-of-the-hearts-electrical-system

John Hopkins Medicine. (2024). Catheter Ablation. Www.hopkinsmedicine.org. https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/catheter-ablation

Khakham, C. (2023, June 1). Try These 10 Game-Changing Supplements To Support Your Heart Health. Rupa Health. https://www.rupahealth.com/post/integrative-cardiology-lifestyle-and-natural-approaches-to-heart-health

Mayo Clinic. (2021, September 16). How calcium channel blockers are used. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/high-blood-pressure/in-depth/calcium-channel-blockers/art-20047605

Mayo Clinic. (2022, April 30). Supraventricular Tachycardia - Symptoms and Causes. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/supraventricular-tachycardia/symptoms-causes/syc-20355243

Mayo Clinic. (2024, April 2). Electrocardiogram (ECG or EKG). Mayoclinic.org; Mayo Clinic. https://www.mayoclinic.org/tests-procedures/ekg/about/pac-20384983

Mayo Clinic. (2025a). Flecainide (oral route). Mayo Clinic. https://www.mayoclinic.org/drugs-supplements/flecainide-oral-route/description/drg-20063854#drug-proper-use

Mayo Clinic. (2025b). Flecainide (oral route). Mayo Clinic. https://www.mayoclinic.org/drugs-supplements/flecainide-oral-route/description/drg-20063854#drug-precautions

Mayo Clinic. (2025c). Flecainide (oral route). Mayo Clinic. https://www.mayoclinic.org/drugs-supplements/flecainide-oral-route/description/drg-20063854#drug-before-using

MedlinePlus. (2016a). Flecainide: MedlinePlus Drug Information. Medlineplus.gov. https://medlineplus.gov/druginfo/meds/a608040.html#side-effects

MedlinePlus. (2016b). Flecainide: MedlinePlus Drug Information. Medlineplus.gov. https://medlineplus.gov/druginfo/meds/a608040.html#precautions

MedlinePlus. (2016c). Flecainide: MedlinePlus Drug Information. Medlineplus.gov. https://medlineplus.gov/druginfo/meds/a608040.html#if-i-forget

MedlinePlus. (2017, March 15). Amiodarone: MedlinePlus Drug Information. Medlineplus.gov. https://medlineplus.gov/druginfo/meds/a687009.html

Pratt, C. M., & MoyéL. A. (1995). The Cardiac Arrhythmia Suppression Trial. Circulation, 91(1), 245–247. https://doi.org/10.1161/01.cir.91.1.245

Robinson, K. (2025, January 6). Cough Suppressants Explained: Relief for Every Type of Cough. Rupa Health. https://www.rupahealth.com/post/cough-suppressants-explained-relief-for-every-type-of-cough

Ruskin, J. N., A. John Camm, Dufton, C., Woite-Silva, A. C., Tuininga, Y., Badings, E., S.S.G, J., Oosterhof, T., Aksoy, I., Aaf F.M. Kuijper, Van, I. C., Vincent van Dijk, Dieter Nuyens, Schellings, D., Mark Young Lee, Kowey, P. R., Harry J.G.M. Crijns, Maupas, J., & Belardinelli, L. (2024). Orally Inhaled Flecainide for Conversion of Atrial Fibrillation to Sinus Rhythm. JACC. Clinical Electrophysiology, 10(6), 1021–1033. https://doi.org/10.1016/j.jacep.2024.02.021

Somberg, J. (2024). The Resurgence of Flecainide. Cardiology Research, 15(2), 67–68. https://doi.org/10.14740/cr1642

Supraventricular Tachycardia (SVT). (2020). Www.nationwidechildrens.org. https://www.nationwidechildrens.org/conditions/supraventricular-tachycardia

Varanasi-Diaz, S. (2024, February 8). 10 Commonly Prescribed Medications and the Foods That Should Be Avoided with Them. Rupa Health. https://www.rupahealth.com/post/10-commonly-prescribed-medications-and-the-foods-that-should-be-avoided-with-them

Ventricular Tachycardia. (2022, June 12). Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/17616-ventricular-tachycardia

Yoshimura, H. (2023, October 17). What is The Gut-Liver Axis? Rupa Health. https://www.rupahealth.com/post/what-is-the-gut-liver-axis

Yoshimura, H. (2024a, April 12). Nutritional interventions in heart failure care. Rupa Health. https://www.rupahealth.com/post/nutritional-interventions-in-heart-failure-care

Yoshimura, H. (2024b, May 31). Exercise Protocols for Cardiac Rehabilitation and Heart Failure. Rupa Health. https://www.rupahealth.com/post/exercise-protocols-for-cardiac-rehabilitation-and-heart-failure

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Medication Fact Sheets
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.